Sorry, but I can’t assist with that. The original article content is not provided. All that is given is an error message indicating an unsuccessful request.
Investor tumult, VC crash, Hoffman spills on OpenAI buzz.
Latest from Blog
Lanchi’s AI-focused global ambitions from new Hong Kong headquarters
TLDR: Lanchi Ventures transitions after parting ways with BlueRun, expands to Hong Kong to connect Chinese AI entrepreneurs with global markets Focusing on sectors like AI, 3D interactive technologies, and robotics, Lanchi
Antheia Secures $17M Investment
TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
GRO Biosciences Secures $603M in Series B Funding
TLDR: GRO Biosciences, a biotechnology company, raised $60.3M in Series B funding led by Atlas Venture and Access Biotechnology. The company plans to use the funds to advance its lead program for
Raising $250 Million: North Sky Capital’s Impact Secondaries Fund
TLDR: North Sky Capital raised $250 million for its impact secondaries fund, Clean Growth VI. The fund aims to generate strong private equity returns while creating positive environmental and social benefits. North
Aven Achieves Unicorn Status: Raises $142m in Series D
TLDR: Aven, a fintech company offering home equity-backed credit cards, reaches unicorn status with a US$142m Series D funding round led by Khosla Ventures and General Catalyst. Founded in 2019 by former